Risk of hypertension in people with HIV in the USA initiating modern antiretroviral regimens: pooled analysis of blood pressure data from five clinical trials
Results suggest the risk of hypertension is not significantly different across INSTI/TAF, INSTI/non-TAF and NNRTI/non-TAF regimens.
Authors
- Andrew Whiteman (ORCID: https://orcid.org/0000-0002-5107-0506)
- Andrea Marongiu (ORCID: https://orcid.org/0000-0001-7038-3615)
- Carrie M. Nielson
- Juergen Rockstroh
- Keith Aizen (ORCID: https://orcid.org/0009-0009-2763-8745)
- L. J. Waters
- Calvin Cohen
- Yuan Tian
- Anchalee Avihingsanon
- Chloe Orkin
- Juan Manuel Tiraboschi
Institutions
- Chulalongkorn University (TH)
- Queen Mary University of London (GB)
- University of California, San Francisco (US)
- Central and North West London NHS Foundation Trust (GB)
- University Hospital Bonn (DE)
- Bellvitge University Hospital (ES)
- Gilead Sciences (United Kingdom) (GB)
- HIV Netherlands Australia Thailand Research Collaboration (TH)
- Gilead Sciences (United States) (US)
- University of San Francisco (US)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2026-02-02
- DOI
- https://doi.org/10.1093/jac/dkag005
- Primary Topic
- HIV-related health complications and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00